The customer observed falsely decreased hemoglobin results generated on the alinity hq analyzer for one sample.The following results were provided: (b)(6) 2023, sid (b)(6), alinity hq initial result 7.9 g/dl, new sample hemoglobin result was 15.6 g/dl.(b)(6) 2023, sid (b)(6), repeat result of original sample on cell-dyn sapphire the next day 15.3 g/dl.No impact to patient management was reported.
|
Updated information in section g: contact office address 1, contact office city, contact office postal code, contact office country, contact office first and last name, contact office email, contact office phone number, contact office fax number the field service engineer (fse) inspected the alinity hq analyzer and replaced staging tubing for rbc line, small check valves for the wbc line tubing, the staging pump and small check valves, and waste tubing from optics.A leaking fitting causing a pressure/vacuum leak was replaced.A review of tracking and trending did not identify any trends associated with the complaint issue.Labeling was reviewed and found to be adequate.The flow cytometry standard (fcs) files and the initial result printout from the alinity hq and the repeat result printout from the cell-dyn sapphire were provided by the customer for specimen id (sid) (b)(6).Review of the fcs files determined no algorithm issue was found.Review of the printouts and complaint notes confirmed the result observed by the customer.Based on the investigation, no systemic issue or deficiency of the alinity hq analyzer, sn (b)(6)was identified.All available patient information was included.Additional patient details are not available.
|